Malaria screening: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
m (Changes made per Mahshid's request) |
||
Line 25: | Line 25: | ||
[[Category:Tropical disease]] | [[Category:Tropical disease]] | ||
[[Category:Deaths from malaria]] | [[Category:Deaths from malaria]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 18:00, 18 September 2017
Malaria Microchapters |
Diagnosis |
---|
Treatment |
Case studies |
Malaria screening On the Web |
American Roentgen Ray Society Images of Malaria screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Overview
Screening of malaria is important in Sub-Saharan refugees and blood donors.[1]
Screening
Screening for malaria infection is important in:[1]
- Sub-Saharan refugees
- A sub-optimal alternative to presumptive therapy is to test newly arriving for malaria infection.
- Studies have demonstrated that a single malaria thick-and-thin blood smear lacks sensitivity for detecting asymptomatic or sub-clinical malaria in these populations.
- Three separate blood films taken at 12 to 24 hour intervals, the standard recommendation for diagnosis of clinical malaria, has a greater sensitivity. However, this approach is rarely feasible for screening newly arriving refugee populations because of cost constraints and the need for multiple visits.
- When a refugee does not receive presumptive therapy they should be monitored for signs or symptoms of disease, particularly during the initial 3 months after arrival, regardless of the post-arrival testing results.
- Blood donors
References
- ↑ 1.0 1.1 "Immigrant and Refugee Health".
- ↑ Lee SH, Kara UA, Koay E, Lee MA, Lam S, Teo D (2002). "New strategies for the diagnosis and screening of malaria". Int J Hematol. 76 Suppl 1: 291–3. PMID 12430867.